Saharan et al. Dissolution Enhancement of DrugsReprinted from International Journal Health Research Peer-reviewed Online Journal Abstracting/Indexing
African Index Medicus, Open-J-Gate, Directory of Open Access Journals (DOAJ), Socolar,
Saharan et al. Dissolution Enhancement of DrugsInternational Journal of Health Research
The International Journal of Health Research is an online international journal allowing free unlimited access to abstract and full-text of published articles. The journal is devoted to the promotion of health sciences and related disciplines (including medicine, pharmacy, nursing, biotechnology, cell and molecular biology, and related engineering fields). It seeks particularly (but not exclusively) to encourage multidisciplinary research and collaboration among scientists, the industry and the healthcare professionals. It will also provide an international forum for the communication and evaluation of data, methods and findings in health sciences and related disciplines. The journal welcomes original research papers, reviews and case reports on current topics of special interest and relevance. All manuscripts will be subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication) will be published without delay. The maximum length of manuscripts should normally be 10,000 words (20 single-spaced typewritten pages) for review, 6,000 words for research articles, 3,000 for technical notes, case reports, commentaries and short communications. Submission of Manuscript: The International Journal of Health Research uses a journal management software to allow authors track the changes to their submission. All manuscripts must be in MS Word and in English and should be submitted online at http://www.ijhr.org. Authors who do not want to submit online or cannot submit online should send their manuscript by e-mail attachment (in single file) to the editorial office below. Submission of a manuscript is an indication that the content has not been published or under consideration for publication elsewhere. Authors may submit the names of expert reviewers or those they do not want to review their papers.
The Editorial Office International Journal of Health Research
Madonna University, Elele Campus, Rivers State
E-mail: [email protected] or [email protected]Saharan et al. Dissolution Enhancement of DrugsInternational Journal of Health Research, June 2009; 2(2): 107-124 (e222p3-20)
Poracom Academic Publishers. All rights reserved.
Review Article Dissolution Enhancement of Drugs. Part I: Technologies and Effect of Carriers Received: 03-Dec-08 Revised: 12-Apr-09 Accepted: 05-May-09 Abstract
For complete absorption and good bioavailability of orally
Vikas A Saharan1
administered drug, the drug must be dissolved in gastric fluids. Dissolution of drug is the rate-controlling step which
Vipin Kukkar1
determines the rate and degree of absorption. Drugs with slow dissolution rates generally show erratic and incomplete
Mahesh Kataria1
absorption leading to low bioavailability when administered orally. Since aqueous solubility and slow dissolution rate of
Manoj Gera1
BCS class II and class IV drugs is a major challenge in the
Pratim K Choudhury2
drug development and delivery processes, improving
aqueous solubility and slow dissolution of BCS Class II and
Class IV drugs have been investigated extensively. Various
techniques have been used in attempt to improve solubility
and dissolution rates of poorly water soluble drugs which
formulations, melt granulation, direct compaction, solvent
evaporation, coprecipitation, adsorption, ordered mixing,
Sciences, ML Sukhadia University, Udaipur, Rajasthan, India
liquisolid compacts, solvent deposition inclusion complexation and steam aided granulation. In these techniques carrier
plays an important role in improving solubility and dissolution
For Correspondence:
Vikas A Saharan, Assistant
enhancement in drugs. This part of this review discusses
enhancement of drugs while Part II [Int J Health Res, Sept
Bihani S. D. College of Technical Education, Gaganpath, Sri
2009; 2(3)] describes the role and applications of
cyclodextrins, carbohydrates, hydrotropes, polyglocolized
glycerides, dendrimers, acids and miscellaneous carriers in
Tel: +91-154-2466777 Fax: +91-154-2466774
Keywords: Dissolution enhancement; aqueous solubility,
water soluble carriers; BCS class II, excipients.
Saharan et al. Dissolution Enhancement of Drugs Introduction
characteristics of the particles. Part I of this
Nearly one-third of drugs in development are
water insoluble and one-half fail in trials
soluble drugs as well as role of few water
kinetics [1]. These poorly water soluble drugs
are allied with slow drug absorption leading
dissolution enhancement. While part II [Int J
to inadequate and variable bioavailability and
Health Res, Sept 2009; 2(3)] describes use
G.I. mucosal toxicity of drugs [2]. Poorly
of cyclodextrins, carbohydrates, hydrotropes,
water soluble drugs belong to BCS class II
polyglocolized glycerides, dendrimers, acids
and Class IV [3] group of compounds. In the
process of absorption of drug from oral route
dissolution is the rate limiting step for
lipophilic drugs. Therefore it is necessary to
Techniques for Dissolution Enhan-
enhance dissolution of these drugs to ensure
maximum therapeutic utility of these drugs.
Before studying the various approaches to
There are several techniques reported in
literature for formulation of hydrophobic
understand the basic process of dissolution. Dissolution is a process by which a solid
drugs with enhanced dissolution rate. These
substance goes into solution. The extent to
techniques are carefully selected on the
basis of properties of drug, excipients and
given set of conditions is referred to as the
solubility of the substance in the solvent i.e.
rate of solution (dissolution) and amount that
Solid Dispersion
can be dissolved (solubility) are not same.
The dissolution rate of a drug is directly
Solid dispersion is defined as a dispersion of
proportional to its solubility as per Noyes-
one or more active ingredients in an inert
Whitney equation and therefore solubility of a
carrier or matrix at solid state prepared by
the melting (fusion), solvent, or melting-
determines its dissolution rate and hence its
solvent method [6]. In melting method carrier
absorption and bioavailability eventually [4].
is melted and drug is added with stirring and
melted until homogenous melt is obtained
The various properties of drug that affect
which is then cooled to room temperature
while in solvent method drug and carrier is
solubility, particle size, polymorphism, salt
dissolved in minimum amount of solvent and
form, complexation, wettability, etc [5] and
can be targeted to enhance dissolution of
reduced pressure [7]. Solid dispersions are
poorly water soluble drugs. Use of water
also prepared by dissolving drug and carrier
soluble excipients is common and simplest
in a common solvent followed by evaporation
hydrophobic drugs. These excipients namely
involves use of heating and solvent action to
polymers, superdisintegrants, carbohydrates,
dissolve the drug and carrier in solvent
surfactants hydrotropes, acids etc work in
followed by evaporation of the solvent. Solid
different ways to enhance water solubility of
dispersion technique improves the solubility,
drugs. The role of techniques of preparation
of formulation is as imperative as the choice
bioavailability of poorly water-soluble drugs
of the carriers to enhance dissolution of
crystallinity of the product and surface
Saharan et al. Dissolution Enhancement of Drugs
Solid inclusion complexes can be prepared
dispersions can be ascribed to a number of
paste. Drug is then added and kneaded for
specified time. The kneaded mixture is then
2. The reduction of particle size to nearly a
dried and passed through sieve if required
carrier dissolves, the insoluble drug is
fine particles leading to an increase in
both surface area and solubilization for
solution of β-CD. The system is kept under magnetic agitation with controlled process
parameters and protected from the light. The
formed precipitate is separated by vacuum
4. The presence of carrier may also prevent
filtration and dried at room temperature in
order to avoid the loss of the structure water
resulting in decreased interfacial tension
Drug is added in alkaline solution like sodium
hydroxide, ammonium hydroxide. A solution
of β- Cyclodextrin is then added to dissolve
presence of carrier polymers also inhibits
the joined drug. The clear solution obtained
neutralized using HCl solution until reaching
5. Cosolvent effect on the drug by the water
the equivalence point. At this moment, the
appearance of a white precipitate could be
6. Intermolecular hydrogen bonds between
appreciated, corresponding to the formation
of the inclusion compound. The precipitate is then filtered and dried [16].
7. Local solubilization effect of carrier at the
Various factors affecting dissolution of drug
from solid dispersion includes the method of
physical mixture is introduced in a suitable
preparation of the solid dispersion, amount
mill like oscillatory mill and grinded for
and properties of the polymer carriers, drug
Inclusion Complexation
Drug is dissolved in suitable solvent and the
required stoichiometric amount of carrier
This is most widely used method to enhance
material like β cyclodextrin is dissolved in
water solubility and increase stability of
hydrophobic drugs by using cyclodextrins.
Saharan et al. Dissolution Enhancement of Drugs
produce a clear solution, which is then spray-
a reduction in particle-particle agglomeration
or by reducing van der Waal’s interactions.
Increase in true surface area of the ordered
inherent surface roughness and porosity of
Drug and cyclodextrins mixture is reacted in
the microcrystalline cellulose-drug mixture
microwave oven to form inclusion. It is a
novel method for industrial scale preparation
Lipid-based formulations
reaction time and higher yield of product [17].
Lipid-based delivery systems like emulsions,
Steam-Aided Granulation
microemulsions, liposomes, microspheres,
solid-lipid nanoparticles, etc have ability to
Steam instead of water can be used in wet
granulation because it provides a higher
barriers to oral absorption and are most
diffusion rate into the powder and a more
successful in enhancing the bioavailability of
favorable thermal balance during the drying
molecules that are poorly water-soluble but
step. After condensation of the steam, water
highly permeable drug molecules (BCS class
forms a hot thin film, requiring only a small
II). Some proposed mechanisms of action of
amount of extra energy for its elimination and
evaporates more easily. The use of steam
bioavailability of compounds include [21]:
instead of liquid water in a wet granulation
a) Particle size reduction to molecular size
amount of water used and as a result the
yielding a solid-state solution within the
b) Enhanced wetting of hydrophobic solids
Cogrinding / Comicronization
Cogrinding of a poorly water-soluble drug
aqueous environment from oil droplets of
hydroxypropyl methylcellulose (HPMC), poly vinyl alcohol (PVA) etc in the presence of
d) Promotion of absorption via intrinsic lipid
small amount of water is extremely effective
maintenance of drug crystallinity to some
extent [19]. Small particles produced by
environment of the gastrointestinal tract.
Melt-Granulation
enhanced dissolution rate. However, energy
added to reduce particle size results in
increased van der Waal’s interactions and
efficiently agglomerated by the use of a
electrostatic attraction between particles
meltable binder which can be a molten liquid,
leading to reduce effective surface area due
a solid or a solid that melts during the
to agglomeration thus decreasing dissolution
process usually in high shear mixers, where
the product temperature is raised higher than
excipients like microcrystalline cellulose can
the melting point of the binder either by a
heating jacket or, when the impeller speed is
eliminate cohesive and electrostatic forces.
This approach increases apparent surface
generated by the impeller blades [22]. In this
technique no water or organic solvents are
creating an ordered mixture, thereby causing
Saharan et al. Dissolution Enhancement of Drugs
needed and there is no drying step therefore
the drug/polymer composition is decisive in
the process is environmentally safe, less
preventing phase separation during freezing,
time consuming and uses less energy than
allowing for the active to be molecularly
dispersed with the polymer. Recrystallization
of the drug is avoided by the inclusion of high
glass-transition temperature (Tg) polymers
solution properties, low melting point, rapid
such as PVP or hypromellose (HPMC). This
solidification rate, low toxicity and little cost
technique is widely applicable to enhance in-
[22]. The increase in dissolution rate can be
ascribed to the hydrophilic character of the
system due to the presence of water-soluble
carriers and the fact that the drug forms
Coevaporate System/ Coprecipitation Direct Compaction
maleate contain good solubility in acidic pH
but in alkaline pH solubility is significantly
In this process polymer like hydroxypropyl
methylcellulose and drug is dry-blended,
formulation containing weak base is given
compressed into slugs and then milled into a
orally precipitation of poorly soluble free
base occurs within formulation in intestinal
enhanced dissolution rate of poorly water-
fluid. Precipitated drug is no longer capable
soluble drugs without the use of solvent or
heat addition to overcome the disadvantages
decrease in bioavailability of drug. This
of solid dispersion by these methods. This
process is also cost effective and quicker.
The compaction processes are believed to
carrier with solubilizing effect in alkaline
be particularly effective at enhancing the rate
intestinal fluid which may operate in the
microenvironment, immediately surrounding
particles are maintained in direct contact with
the drug particle and polymers for controlling
the polymer particles during drug dissolution,
the dissolution rate to formulate dosage
in contrast with a physical mixture where the
forms ensuring maximum bioavailability with
disperse and be separated in the dissolution
Ordered/Interactive Mixing Solvent Evaporation by Ultra-Rapid
Ordered mixing is described as method to
Freezing (URF)
prepare ordered units in the mix such that
the ordered unit will be the smallest possible
contained in a polymer solution onto the
identical composition to all the other ordered
units in the mix. Ordered mixing yields nearly
thermal conductivity (k) between 10 and 20
the perfect mix and may be obtained in a
W/(m K), collecting the frozen particles and
adhesion, coating and other methods [27].
conductive heat transfer, resulting in high
Prerequisite for fast dissolution from an
supersaturation and nucleation rates, the
ordered mixture includes that the carrier
URF technology has the potential to create
particle should dissolve rapidly, delivering a
fine particulate suspension of drug particles
properties, similar to those produced by
[28]. Higher concentration of drug shows
other rapid freezing technologies. As in other
reduced dissolution rates particularly at
freezing technologies, the rapid freezing of
Saharan et al. Dissolution Enhancement of Drugs
because high concentration of drug forms
agglomerates rather than discrete particles
sieve. The Increase in the dissolution rate is
with resulting decreased surface area and
ascribed to the reduced particle size of the
thicker diffusional layers causing reduction in
drug deposited on the carrier and enhanced
dissolution rates [29]. In an ordered powder
wettability of the particles brought about by
mix fine drug particles are distributed fairly
evenly on coarse carrier particles. The drug
powder is therefore deagglomerated in the
Carriers for Dissolution Enhance-
dry state. This may be used to increase the
dissolution rate of drug powders because a
larger contact surface area is exposed to the
Carriers, which are soluble and dissolve in
water at a fast rate, are widely used in
Adsorption of Drugs onto High Surface
dissolution of drugs. The carriers which have
Area Carriers
been reported in literature are presented in
Table 1 and are described in detail under
carriers having large surface area (like
crosslinked polyvinylpyrrolidone, Kollidone)
Polymers
from solutions of the drug in appropriate
solvents like methanol, polyethylene glycol,
Polymers like polyethylene glycols (PEGs),
and 2-pyrrolidone. The dissolution rate of
drug increases due to increase in surface
area and drug particles have good wettability
polyvinylpyrrolidone (PVP) etc when used in
due to the surrounding solubilising materials
optimum concentration lead to increase in
dissolution rate due to reduction in particle
size, solubilization effect of the carrier,
Liquisolid Compacts
formation of hydrogen bonds between drug
Liquid Compacts are compressible powdered
and carrier (Table 2). When polymers are
“liquisolid medication” implies oily liquid
decrease dissolution rate due to leaching out
drugs and solutions or suspensions of water-
of the carrier during dissolution which might
form a concentrated layer of solution around
the drug particles and the migration of the
released drug particles to the bulk of the
converted into a dry, non-adherent, free
Solid dispersions (SDs) of glyburide were
excipients such as the carrier and coating
material. Surfactants like tweens are used to
improve aqueous solubility of poorly soluble
selected solid dispersions were lyophilized.
Solvent Deposition / Evaporation
In this technique drug is dissolved in a
glyburide/PEG 4000, 1:10, showed an 8-fold
solvent like methylene chloride to produce a
and dispersion containing 6 parts of PEG
clear solution. The carrier is then dispersed
mixture show 12-fold increase as compared
in the solution by stirring and the solvent is
removed by evaporation under temperature
dispersions further supplement dissolution
and pressure. The resultant mass is then
Saharan et al. Dissolution Enhancement of DrugsTable 1: Classification of carriers enhancing dissolution of drugs
Polyvinylpyrrolidone, Polyvinylpolypyrrolidone, Polyvinyl alcohol, Polyethylene glycols, Hydroxypropyl methylcellulose, Hydroxypropyl cellulose, Poly (2-hydroxyethylmethacrylate), Methacrylic copolymers (Eudragit® S100 sodium salts and Eudragit® L100 sodium salts)
Sodium starch glycolate, Croscarmellose sodium, Cross-linked polyvinylpyrrolidone, Cross-linked alginic acid, Gellan gum, Xanthan gum, Calcium silicate
β-Cyclodextrins, Hydroxypropyl-β-cyclodextrins
Lactose, Soluble starch, Sorbitol, Mannitol, β-(1-4)-2-amino-2-deoxy-D-glucose (Chitosan), Maltose, Galactose, Xylitol, Galactomannan, British gum, Amylodextrin
Poloxamers (Lutrol® F 127, Lutrol® F 68), Polyglycolized glyceride (Labrasol), Polyoxyethylene sorbitan monoesters (Tweens), Sorbitan esters (Spans), Polyoxyethylene stearates, Poly (beta-benzyl-L-aspartate) -b- poly (ethylene oxide), Poly (caprolactone) -b- poly (ethylene oxide)
Urea, Nicotinamide, Sodium benzoate, Sodium salicylate, Sodium acetate, Sodium-o-hydroxy benzoate, Sodium-p-hydroxy benzoate, Sodium citrate
Gelucire 44/14, Gelucire 50/13, Gelucire 62/05
Citric acid, Succinic acid, Phosphoric acid
Microcrystalline cellulose, Dicalcium phosphate, Silica gel, Sodium chloride, Skimmed milk
due to increase in surface area and hence
PVP ratio. The drug:PVP in 1:4 ratio, solid
dispersion gave highest dissolution rate of
about a 38-fold higher than that of pure drug [12].
Solid dispersions of norfloxacin with PEG
6000 in weight ratios of 10:90, 20:80, 30:70
and 50:50 were prepared by fusion method.
Solubility studies revealed no significant
fusion method involving heating a physical
increase in solubility of norfloxacin on
addition of PEG. Dissolution studies showed
4000 or PEG 6000 in 1:2, 1:4, 1:6 and 1:8
maximum dissolution rate of drug with PEG
drug/carrier ratios, to the liquid state.
Dissolution studies suggested that the dissolution of carbamazepine from the solid
establishing the effect and importance of
optimum weight fraction of polymer [33].
molecular weight nor the weight fraction of
Solid dispersions of piroxicam were prepared
solid dispersion may be ascribed to complex
using polyvinylpyrrolidone K-30 in 1:0.5, 1:1,
1:2, 1:3, 1:5 and 1:6 ratio of drug to polymer
by solvent method. The dissolution of drug in
solid dispersion was dependent on drug to
dispersion with carbamazepine crystalling in
Saharan et al. Dissolution Enhancement of DrugsTable 2: Polymers and techniques employed for enhancing dissolution of poorly water soluble drugs
Increase in surface area and hence surface
free energy resulting in an increase in the dissolution
presence of intermolecular hydrogen bonds between piroxicam and PVP
carbamazepine and PEGs during melting and a polymorphic change during the preparation of solid dispersion, with carbamazepine crystalling in a metastable form of higher dissolution rate
solubilization effect of carrier at the diffusion layer, formation of amorphous phase of piroxicam and particle size reduction resulted from interaction of drug and PEG 4000
Reduction of particle size of the drug and
surface tension lowering effect of carriers resulting in wetting of hydrophobic roxithromycin surface
enhancement of surface area and increase in drug wettability
Saharan et al. Dissolution Enhancement of DrugsTable 2: Polymers and techniques employed for enhancing dissolution of poorly water soluble drugs (continued)
Increased surface area for mass transfer,
thermodynamically enhanced dissolution of a higher energy amorphous form from the carrier, improved wetting and solubilization
Formation of interstitial solid solutions
Higher hydrophilic character of the system
due to the presence of water-soluble carriers and part of the drug dissolved in the binder
Microenvironment surfactant effect where
surfactant concentration in the boundary layer surrounding the drug particles, providing a lower energy pathway for drug dissolution
Increase in solubility driving force, lowering
the heat of solution of the danazol, nano-structured amorphous drug domain, and improved surface area.
Saharan et al. Dissolution Enhancement of Drugs
a metastable form of higher dissolution rate
concentration of polymers from 0.5 to 3 %
polymer solution. Angle of repose and carr’s
Solid dispersions of piroxicam in PEG 4000
index studies indicated fine nature and good
at 1:1, 1:2 and 1:3 ratio of drug to polymer
flow properties of the all formulations [10].
were prepared by fusion and solvent method
with enhanced dissolution due to increased
Solid dispersions of gliclazide were prepared
wettability of drug, a local solubilization effect
using PEG 4000 and PEG 6000 in 1:1, 1:3,
of carrier at the diffusion layer, formation of
and 1:5 ratio of drug to polymer by solvent
amorphous phase of piroxicam and particle
method using chloroform as solvent. Drug:
size reduction resulted from interaction of
carrier ratio of 1:5 was found to be optimum
drug and PEG 4000. Storage stability studies
for improving dissolution rate of gliclazide for
at 25°C and 37° C for 10 weeks showed that
dispersions showed faster dissolution than
uptake of water during storage may occur in
dispersions of albendazole were prepared
piroxicam potency in piroxicam-PEG solid
using PEG 6000 in 1:1, 1:3 and 1:5 ratio of
Solid dispersions of flurbiprofen in PVP,
improved dissolution compared to physical
mixtures owing to increased surface area for
ratio of drug to carrier were prepared by
mass transfer, thermodynamically enhanced
solvent method. Among these polymers PVP
dissolution of a higher energy amorphous
gave highest enhancement (19-fold) in the
form from the carrier, improved wetting and
dissolution rate of flurbiprofen at 9:1 drug to
flurbiprofen with various polymer solutions
Solid dispersions of rofecoxib with PVP, PEG
was in the descending order of PVP, HPMC,
PEG, and HPC at 9:1 ratio of drug to carrier.
w/w were prepared by hot-melt method. The
As concentration of carrier in solid dispersion
solubility efficiency of polymers was in the
was increased, the rate of dissolution was
order of PVP >> PEG 4000 > PEG 6000 due
to high amorphizing properties of PVP than
aggregation of drug and carrier in solid
carrier amoumt i. e. 90% and was ascribed
to the formation of interstitial solid solutions
prepared using PEG 6000 by fusion method.
Solid molecular dispersion of diclofenac
dissolution of glibenclamide compared with
sodium, naproxen and piroxicam using Poly
marketed daonil(R) tablets (Hoechst) due to
improved wettability and dispersibility of drug
hydrogel as carrier were prepared by solvent
from solid dispersion [36]. Solid dispersions
of roxithromycin were prepared using PEG,
HPMC and HPC in 1:1, 1:3, and 1:5 ratio of
naproxen, and 100% acetone for piroxicam.
drug to polymer by coprecipitate method.
The results showed threshold drug loading
The dissolution rate of roxithromycin solid
level of about 30% in these solid dispersions,
dipersions was in the descending order of
Solubility of roxithromycin was directly
polymer improves the compatibility between
Saharan et al. Dissolution Enhancement of Drugs
drug and polymer. Stability studies under
varying conditions of humidity (22-92 RH %)
showed transition from clear sample to an
opaque one on increasing humidity due to
granulation technique using PEG 4000 as a
melt binder without using solvents or water.
Solid-state analysis indicated only a limited
reduction of the crystallinity of the drug and
no changes in its polymeric form. Granulates
showed a significant improvement of in vitro
Coground mixtures of nifedipine, griseofulvin,
intragranular addition of crospovidone (PVP-
dispersing drug in the fused PEG 6000 and
CL) was found to be necessary to produce
tablets with a satisfactory disintegration time
temperature, the solidified mass was ground
using a ball mill. Then solvent like water,
Granules of griseofulvin (2.5, 5.0%) were
added to observe the effect of solvents and
prepared by melt granulation technique using
further ground and dried to remove solvent.
The resultant mass was lightly pulverized to
Dissolution rate of all prepared granules was
participate in the solubility enhancement and
physical mixtures. Granules having PEG as
process through the functional groups in a
small amount of water added (highly polar
environment). Solubility also increased in the
containing Gelucire 44/14 as binder showed
presence of organic solvents suggesting that
a significant dissolution enhancement as
the pulverizing effect for drugs like nifedipine
compared to drug but slightly enhancement
also promote the drug- polymer interactions
compared to physical mixtures. The increase
in dissolution rate was ascribed to the highly
polar environment provided by water-soluble
Lipid based formulations of piroxicam were
carriers, part of the drug dissolved in the
prepared using 1,2-dimyristoyl-sn-glycero-3-
binder and formation of monotectic mixture
phosphatidylcholine (DMPC) phospholipids
alone in 1:1and 2:1 ratio of drug:DMPC and
ratio. Dissolution studies showed highest
carbamazepine at a 1:1 polymer:drug weight
increase in drug release from combination of
lipid with PEG as compared to lipid alone
due to solubilizing effect of PEG on the drug
and E5LV) and methyl cellulose polymers by
thus enhancing the dissolution rate. Storage
slugging and roller compaction method. The
stability studies at 4°, 25° and 60°C revealed
stability of at least 6 months but beyond this
produced comparable rate and extent of drug
decrease in dissolution rates for formulations
dissolution. This method require no solvent
containing PEG 4600 due to formation of a
or heat for formulation and is cost effective,
crystalline mass upon storage for extended
quicker, readily scalable at industrial scale
period. Stabilizers like polyvinyl alcohols can
be added to increase storage stability of all
Saharan et al. Dissolution Enhancement of Drugs
Micronized danazol powders were prepared
drug solubility by two times while maintaining
by ultra rapid freezing using polyvinylpyrro-
the desirable mucoadhesive properties [39].
lidone K-15 at a 1:2 ratio and 0.55% total
solid in either tert-butanol heated to 313 K or
Superdisintegrants
acetonitrile solvent at room temperature with
Dissolution of poorly water soluble drugs can
different solvents markly alters surface
produced by acetonitrile were spherical and
glycolate, croscarmellose sodium,crospovi-
uniform in size as a result of the more rapid
and uniform cooling of the droplets relative to
crosslinked alginic acid etc [40]. Some of the
tert-butanol. This process is viable and
recent studies utilizing superdisintegrants are
robust for producing high surface area nano-
structured powders for enhancing dissolution
Sodium starch glycolate swells 7- to 12-fold
in less than 30 sec. uniformly in all three
Coevaporates of prochlorperazine maleate
dimensions while croscarmellose swells 4- to
8-fold in less than 10 sec. in two dimensions
leaving fibre length similar. This indicates
methylcellulose phthalate as a carrier for
that rate, force, and extent of swelling have
solubilization of drug in alkaline medium and
an important role in disintegrants that work
ethyl cellulose, hydroxypropyl cellulose for
by swelling. Cross-linked PVP swells little
controlling the dissolution rates of weak
(due to absence of cationogenic groups in
the molecule) but returns to its original
Wicking or capillary action also is postulated
to be a major factor in the ability of cross-
Fast-dissolving mucoadhesive microparticles
linked PVP to work as superdisintegrant [41].
for sublingual administration could be a
suitable alternative to fast-dissolving tablets
extensive swelling properties for faster
because the sublingual absorption can be
disintegration. Calcium silicate is a highly
residence time on the mucosa and reducing
wicking action. Cross-linked alginic acid is a
hydrophilic colloidal substance with high
sorption capacity and acts by swelling or
copolymers, namely viz. Eudragit® L sodium
salt and Eudragit® S sodium salt, were used
as effective carriers for the preparation of the
Carrier particles of size from 50 to 1000
microparticles in ratio ranging from 15/85 to
microns with cross-linked sodium (Ac-Di-Sol)
85/15% (m/m) by spray drying. Their intrinsic
disintegrant in an optimum amount of 5 to
dissolution rates are faster than those of
liquid (ethanol) which did not dissolved the
disintegrant or caused the disintegrant to
swell [42]. These carrier particles were mixed
microparticles which was anticipated due to
with micronized oxazepam for 50 hours to
H-bond between the NH group of piroxicam
obtain ordered mixture with surface area
and a CO group of the copolymers. The best
ratios of 0.08, 0.57 and 1.5. With addition of
1% sodium lauryl sulphate in finely dispersed
Eudragit® L sodium salt in the ratio 70/30%
substance in the carrier, the dissolution rate
Saharan et al. Dissolution Enhancement of Drugs Table 3: Superdisintegrants and techniques employed for enhancing dissolution of poorly water soluble drugs
Higher surface area of the carrier and capillary
Swelling action of croscarmellose sodium
Swelling action of sodium starch glycolate,
Faster dissolution from amorphous ibuprofen,
drug deposition on carrier surfaces and polymer swelling
Swelling action of sodium starch glycolate,
Swelling action of sodium starch glycolate,
Saharan et al. Dissolution Enhancement of Drugs
was independent of whether or not the water
solvent contains an additional surfactant [43]
ibuprofen and cross-linked polyvinylpyrroli-
done were prepared as physical mixes, and
markedly that about 90% of the composition
drug was loaded onto the polymer by hot mix
has passed into solution after two minutes.
and solvent deposition method. Increased
dissolution rate of ibuprofen were achieved
Improvement of dissolution rate of nifedipine
by solid deposition on high percentages of
deposition, hot mixes, physical mixes. The
sodium starch glycolate and croscarmellose
increased dissolution rate could be ascribed
to a combination of faster dissolution from
deagglomeration of the micronized drug by
the superdisintegrant particles and solid
carrier surfaces and polymer swelling [48].
swelling superdisintegrants which act as a
Tablets of aspirin were prepared by direct
carrier. As an effect of swelling of the
compression technique using sodium starch
superdisintegrants, the ‘wetted’ surface of
crospovidone as superdisintegrants. It was
wettability and dispersibility of the particulate
comparable for tablets formulated with 1%
croscarmellose sodium, 2% crospovidone, or
Coprecipitates of furosemide-crospovidone
dissolution of aspirin from these tablets
methanol with enhanced dissolution rate due
varied in the following descending order
to association between the functional group
despite the closeness of their disintegration
times: croscarmellose sodium, sodium starch
probably between imino and sulfonylamide
hydrochlorthiazide tablets were prepared by
group of furosemide and carboxyl group of
starch glycolate, croscarmellose sodium as
superdisintegrants with enhanced dissolution
Dispersible tablets of flurbiprofen were
microcrystalline cellulose and sodium starch
glycolate disintegrants alone and in different
dissolved in methanol, polyethylene glycol,
2-pyrrolidone and adsorbed onto the surface
(Kallidone). The solvent binding capacities
4000, 2-pyrrolidone. Improved dissolution
glycolate disintegrated rapidly and gave
faster dissolution of flurbiprofen [46].
surface area of the carrier [30]. Similarly
increase in dissolution rate of naproxen by
starch glycolate (Primogel), Ac-Di-Sol, and
prepared by solvent evaporation method with
enhanced dissolution of tenoxicam. Kollidon
sodium, and crospovidone as disintegrants in
2% w/w concentration were prepared by wet
granulation technique using intragranular
and extragranular methods. Disintegration
Saharan et al. Dissolution Enhancement of Drugs
and dissolution studies revealed intragra-
nular method of application of disintegrants
more suitable which help the tablet to burst
poloxamer 407 as surfactant at 1:1, 1:3, 1:5
into smaller particles as well as it may help to
dissolve the drug faster. Croscarmellose
sodium incorporated intragranular method
gave better results than extragranular method as well as better than sodium starch
solubility enhancement due to surface active
property and critical micellar concentration.
extragranular and intragranular methods for
The albendazole-poloxamer melt (1:5 ratio)
showed 16.1 fold dissolution rate and 9.4 fold in dissolution efficiency as compared to
that of pure drug due to solubilization effect
superdisintegrants is an easy alternate to
enhance dissolution of poorly water soluble
Solid dispersions of rofecoxib were prepared
excipient and changing the methodology of
(Lutrol® F127 and Lutrol® F68) in 50%, 75%
solubility of system was observed due to
superdisintegrants is its cost but overall cost
micellar solubilization and/or reduction of
of formulation is less as compared to opting
activity coefficient of the drug through
specific measure to enhance dissolution.
reduction of hydrophobic interaction(s) and
Surfactants
Several liquisolid compacts were prepared
by dispersing piroxicam in tween 80 as liquid
to prepare liquid medication of the different
drug concentrations with different ratios of
oxide)-poly (ethylene oxide) – poly (propy-
drug:tween 80 ranging from 1:1 to 1:9 using
binary mixture of microcrystalline cellulose
(carrier powder)-silica (coating material) and
aspartate) -b- poly (ethylene oxide), Poly
(caprolactone) -b- poly (ethylene oxide) etc
enhanced dissolution rate because drug is
already in solution in tween 80 and same
time drug is carried by powder particles of
drug solubility by using the amphiphilic
the liquisolid vehicle. Thus, its release is
surfactants is due to lowering surface tension
accelerated due to increased wettability and
between drug and solvent, improvement of
surface availability to the dissolution medium
solubilization of the drugs. Micelles are
Conclusion
macromolecules where unimers are held by
non-covalent interactions. The core of the
Numerous technological advancements have
been introduced for dissolution enhancement
corona/shell allows for their suspension in
of poorly water soluble drugs. Most of these
Saharan et al. Dissolution Enhancement of DrugsTable 4: Surfactants and techniques employed for enhancing dissolution of poorly water soluble drugs
carrier, decreased crystallinity of the product
surface availability of the drug to the dissolution medium
modeling of drug release of a poorly water-soluble
properties like solubility, particle size, crystal
drug using water-soluble carriers. Eur J Pharm
habit etc. Some of the carriers are especially
Amidon GL, Lennernäs H, Shah VP, Crison JR. A
theoretical basis for a biopharmaceutic drug
dispersed in them or by size reduction (co-
classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res
micronization). Complexation of drug with
suitable carrier also alters the solubility and
dissolution characteristics due to extremely
Biopharmaceutical classification system. Indian
high aqueous solubility of the carrier. The
solubility and dissolution rate improvements
Jaiswal SB, Brahmankar DM. Biopharmaceutics
are also expected due to co-solvency effect
and pharmacokinetics. A Treatise; 1999; 25:165.
and solubilisation effect of carriers in
Vadnere MK. Coprecipitates and melts. In:
aqueous vehicles. In a nutshell it could be
Swarbrick J, Boylan, JC, editors. Encyclopaedia of pharmaceutical technology 2nd ed. New York,
USA: Marcel Dekker, Inc.; 2002. 641-647 p.
modifications are an important tool to a
Pan RN, Chen JH, Chen RRL. Enhancement of
formulation scientist in designing immediate
dissolution and bioavailability of piroxicam in solid
and fast release drug delivery systems. The
article continues as Part II [Int J Health Res,
Reddy SJ, Gudsoorkar VR. Solid dispersions of
applications of cyclodextrins, carbohydrates,
gliclazide. Indian Pharmacist Aug. 2005; IV:82-84.
Betageri GV, Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and
10. Patro S, Choudhary AA. Effect of some hydrophilic
polymers on dissolution rate of roxithromycin.
References
11. Karatas A, Nilufer Y, Baykara T. Improved solubility
and dissolution rate of piroxicam using gelucire 44/14 and labrasol. IL Farmaco 2005;60:777-782.
Savic R, Eisenberg A, Maysinger D. Block
mer micelles as delivery vehicles of
Ingkatawornwong S. Properties of solid dispersions
hydrophobic drugs: Micelle-cell interactions. J Drug
of piroxicam in polyvinylpyrrolidone K-30. Int J
Saharan et al. Dissolution Enhancement of Drugs
13. Rouchotas C, Cassidy OE, Rowley G. Comparison
of surface modification and solid dispersion
characterization and optimisation of dissolution
techniques for drug dissolution. Int J Pharm
coevaporates. Int J Pharm 1998;160:251-255.
14. Parikh RK, Mansuri NS, Gohel MC, Sonlwala MM.
27. Lantz, RJ, Schwartz JB. Tablets. In: Lieberman HA,
Dissolution enhancement of nimesulide using
Lachman L, editors. Pharmaceutical dosage forms.
complexation and salt formation techniques. Indian
2nd ed. New York, USA: Marcel Dekker, Inc.; 2005.
15. Moyano JR, Blanco MJA, Gines JM, Giordano F.
28. Nystrom C, Westerberg M. The use of ordered
mixtures for improving the dissolution rate of low
inclusion complexes. Int J Pharm 1997;148:211-
29. Alway B, Sangchantra R, Stewart PJ. Modelling the
16. Doijad RC, Kanakal MM, Manvi FV. Studies on
dissolution of diazepam in lactose interactive
piroxicam beta-cyclodextrin inclusion complexes.
30. Friedrich H, Fussnegger B, Kolter K, Bodmeier R.
17. Deshmukh SS, Potnis VV, Shelar DB, Mahaparale
Dissolution rate improvement of poorly water-
PR. Studies on inclusion complexes of ziprasidone
soluble drugs obtained by adsorbing solutions of
drugs in hydrophilic solvents onto high surface area
carriers. Eur J Pharm Biopharm 2006;62:171-177.
31. Javadzadeh Y, Shadbad MRS, Jalali MB,
18. Cavallari C, Abertini B, Rodriguez MLG, Rodriguez
Nokhodchi A. Enhancement of dissolution rate of
L. Improved dissolution behaviour of steam-
piroxicam using liquisolid compacts. IL Farmaco
granulated piroxicam. Eur J Pharm Biopharm
32. Jalali MB, Maleki N, Garjani A, Khandar AA.
19. Sugimoto M, Okagaki T, Narisawa S, Koida Y,
Enhancement of dissolution rate and anti-
inflammatory effects of piroxicam using solvent
characteristics and bioavailability of poorly water-
deposition technique. Drug Dev Ind Pharm
soluble drug by novel cogrinding method using
water-soluble polymer. Int J Pharm 1998;160:11-
33. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM.
Physicochemical characterization and dissolution
20. Spence JK, Bhattachar SN, Wesley JA, Martin PJ,
of norfloxacin / cyclodextrin inclusion compounds
microcrystalline cellulose. Drug Dev Ind Pharm
34. El-Zein H, Riad L, El-Bary AA. Enhancement of
carbamazepine dissolution: in vitro and in vivo
21. Prabhu S, Ortega M, Ma C. Novel lipid based
evaluation. Int J Pharm 1998;168:209-220.
formulations enhancing the in vitro dissolution and
35. Ganesan V, Sivakumar SM, Kannadasan M.
permeability characteristics of a poorly water-
Enhancement of dissolution rate of flurbiprofen.
soluble model drug, piroxicam. Int J Pharm
36. Tashtoush BM, Al-Qashi ZS, Najib NM. Invitro and
22. Perissutti B, Rubessa F, Mariarosa M, Voinovich D.
invivo evaluation of glibenclamide in solid
Formulation design of carbamazepine fast-release
tablets prepared by melt granulation technique. Int
23. Yang D, Kulkarni R, Behme RJ, Kotiyan PN. Effect
Manavalan R. Studies on mechanism of enhanced
of the melt granulation technique on the dissolution
dissolution of albendazole solid dispersions with
characteristics of griseofulvin. Int J Pharm
crystalline carriers. Indian J Pharm Sci 2006;599-
24. Mitchell SA, Reynolds TD, Dasbach TP. A
38. Zahedi P, Lee PI. Solid molecular dispersions of
compaction process to enhance dissolution of
poorly water-soluble drugs in poly(2-hydroxyethyl
poorly water-soluble drugs using hydrxypropyl
methacrylate) hydrogels. Eur J Pharm Biopharm
methylcellulose. Int J Pharm 2003;250:3-11.
25. Overhoff KA, Engstrom JD, Chen B. Novel ultra-
39. Cilurzo F, Selmin F, Minghetti P. Fast-dissolving
rapid freezing particle engineering process for
mucoadhesive microparticulate delivery system
enhancement of dissolution rates of poorly water-
soluble drugs. Eur J Pharm Biopharm 2007;65:57-
Saharan et al. Dissolution Enhancement of Drugs
Superdisintegrants an economical alternative.
47. Aly AM, Semreen M, Qato MK. Superdisintegrants
41. Rudnic EM, Schwartz JD. Oral solid dosage forms.
In: Gennaro AR, Popovich NG, Marderosian, AHD,
disintegrating tenoxicam tablets via camphor
et al., editors. Remington: The science and practice
of pharmacy. 20th ed. Philadelphia: Lippincott
48. Williams AC, Timmins P, Lu M, Forbes RT.
Disorders and dissolution enhancement: deposition
42. Nystrom C, Westerberg M, Nilsson P. A
of ibuprofen on to insoluble polymers. Eur J Pharm
pharmaceutical composition. WO 89/06533 to
49. Zhao N, Augsburger LL. Functionality comparison
43. Nystrom C, Westerberg M. A pharmaceutical
of 3 classes of superdisintegrants in promoting
composition for rapid release of the active
aspirin tablet disintegration and dissolution. AAPS
component comprising an orderred mixture and a
surfactant. WO 90/04962 to Kabivitrum AB,
50. Zhao N, Augsburger LL. The influence of swelling
capacity of superdisintegrants in different pH media
44. Bolhuis GK, Zuurman K, Wierik GHP. Improvement
on the dissolution of hydrochlorthiazide from
of dissolution of poorly soluble drugs by solid
directly compressed tablets. AAPS PharmaSciTech
deposition on a super disintegrant. II. the choice of
super disintegrants and effect of granulation. Eur J
51. Bettinetti G, Mura P. Dissolution properties of
naproxen in combination with polyvinylpyrrolidone.
45. Shin SC, Oh IJ, Lee YB, Choi HK, Choi JS.
52. Pandey VP, Reddy VK, Amarnath R. Formulation
coprecipitating or cogrinding with crospovidone. Int
and evaluation of chloroquine phosphate tablets
using some disintegrants. Indian Pharmacist
46. Manvi FV, Hiremath BK, Kulkarni AS, Chalikwar
SS. Formulation and evaluation of dispersible
Dear Student-Athlete/Parent/Guardian, Please review all the forms in this packet. Each of the form contains information important to the student- athlete. Forms are located on the front and back of each page. Please complete, sign and date each form. Please return forms to MSU-Northern Athletic Training only! Please review the forms for completeness. Incomplete forms or information found
REPORT OF THE COMMITTEE ON PARASITIC DISEASES Vice Chair: J. Mathews Pound, Kerrville, TX Bob H. Bokma, MD; Corrie C. Brown, GA; Leroy M. Coffman, Fl; A. A. Cuthbertson, NV; J. Kieth Flanagan, FL; John E. George, TX; Chester A. Gipson, MD; Larry L. Hawkins, MO; Thomas J. Holt, FL; Lee C. Jan, TX; Ralph C. Knowles, FL; Ulysses J. Lane, NC; Linda L. Logan, APO; Terry F. McElwain, WA; Daniel G.